These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32839811)

  • 1. Reintegrating droperidol into emergency medicine practice.
    Mattson A; Friend K; Brown CS; Cabrera D
    Am J Health Syst Pharm; 2020 Oct; 77(22):1838-1845. PubMed ID: 32839811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency medicine updates: Droperidol.
    Cisewski D; Long B; Gottlieb M
    Am J Emerg Med; 2022 Mar; 53():180-184. PubMed ID: 35063889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of droperidol in behavioural emergencies.
    Shale JH; Shale CM; Mastin WD
    Expert Opin Drug Saf; 2004 Jul; 3(4):369-78. PubMed ID: 15268653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Droperidol in the emergency department: is it safe?
    Richards JR; Schneir AB
    J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department.
    Perkins J; Ho JD; Vilke GM; DeMers G
    J Emerg Med; 2015 Jul; 49(1):91-7. PubMed ID: 25837231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone for sedation of the agitated ED patient.
    Martel ML
    Am J Emerg Med; 2004 May; 22(3):238. PubMed ID: 15138973
    [No Abstract]   [Full Text] [Related]  

  • 7. Droperidol Use in the Emergency Department: A Clinical Review.
    Siegel RB; Motov SM; Marcolini EG
    J Emerg Med; 2023 Mar; 64(3):289-294. PubMed ID: 36925442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droperidol, QT prolongation, and sudden death: what is the evidence?
    Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
    Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectiveness.
    Macht M; Mull AC; McVaney KE; Caruso EH; Johnston JB; Gaither JB; Shupp AM; Marquez KD; Haukoos JS; Colwell CB
    Prehosp Emerg Care; 2014; 18(3):375-80. PubMed ID: 24460451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of droperidol in a United States emergency department.
    Gaw CM; Cabrera D; Bellolio F; Mattson AE; Lohse CM; Jeffery MM
    Am J Emerg Med; 2020 Jul; 38(7):1310-1314. PubMed ID: 31831345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droperidol use in pediatric emergency department patients.
    Szwak K; Sacchetti A
    Pediatr Emerg Care; 2010 Apr; 26(4):248-50. PubMed ID: 20401969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Large Retrospective Cohort of Patients Receiving Intravenous Olanzapine in the Emergency Department.
    Martel ML; Klein LR; Rivard RL; Cole JB
    Acad Emerg Med; 2016 Jan; 23(1):29-35. PubMed ID: 26720055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droperidol--behind the black box warning.
    Horowitz BZ; Bizovi K; Moreno R
    Acad Emerg Med; 2002 Jun; 9(6):615-8. PubMed ID: 12045077
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA response to droperidol black box warning editorials.
    Rappaport BA
    Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
    [No Abstract]   [Full Text] [Related]  

  • 15. A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients.
    Shale JH; Shale CM; Mastin WD
    J Clin Psychiatry; 2003 May; 64(5):500-5. PubMed ID: 12755651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. News flash: Old Mother Hubbard reports the cupboard is bare...time for the FDA to let droperidol out of the (black) box.
    Faine B; Hogrefe C
    Ann Pharmacother; 2012 Sep; 46(9):1259-61. PubMed ID: 22828973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
    [No Abstract]   [Full Text] [Related]  

  • 18. Con: The black box warning on droperidol should not be removed (but should be clarified!).
    Ludwin DB; Shafer SL
    Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
    [No Abstract]   [Full Text] [Related]  

  • 19. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droperidol's effect on QT interval.
    Martinez JB; Moos DD; Dahlen LL
    J Perianesth Nurs; 2006 Apr; 21(2):82-7. PubMed ID: 16600828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.